July/August 2023

Featured Article

Clinical Pathways GPS

Clinical Practice Guidelines for Assessing Health of Older Adults

08/07/2023

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Richard G. Stefanacci, DO, discusses how clinical pathways can provide a framework for conducting assessments, promoting independence, and determining the level of caregiver support needed for older adults.

Richard G. Stefanacci, DO,...

08/07/2023

Journal of Clinical Pathways

Editor's Page

Addressing Disparities in Cancer Care Among Transgender Patients

08/07/2023

Winston Wong, PharmD, Editor-in-Chief

Editor-in-Chief, Winston Wong, PharmD, provides insights on the features in this issue, including the current conversation regarding inequities in health care services for transgender patients.

Editor-in-Chief, Winston Wong,...

08/07/2023

Journal of Clinical Pathways

Research Reports

Oncology Pathways Drive Adoption of High-Quality Treatment Regimens and Deliver Drug Cost Savings

08/07/2023

Kathryn Christensen, MS

Timothy Dollear, MD

Rama Al Ghannam, PharmD

Eric Gratias, MD, FAAP

Robinson Ortiz, MD

Stephen Hamilton, MD

Kathryn Christensen, MS, and colleagues share the initial results of the launch of Cigna and eviCore Healthcare’s Oncology Value-based Pathways program.

Kathryn Christensen, MS, and...

08/07/2023

Journal of Clinical Pathways

Perspectives

Leveraging Quality Measurement to Drive Equitable Cancer Care for Transgender Individuals

08/07/2023

Elizabeth Donckels, MSPH

Nina Regenold, MSc

Theresa Schmidt, MA

Will Nolan

Scout

Don S. Dizon, MD

Tom Valuck, MD, JD

Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.

Elizabeth Donckels, MSPH, and...

08/07/2023

Journal of Clinical Pathways

Column

Trending From ACCC

Delivery of Psychosocial Care in Oncology Summit

08/08/2023

Association of Community Cancer Centers

This column summarizes the sessions from the Association of Community Cancer Centers (ACCC) multistakeholder meeting, “A Call to Action: Delivery of Psychosocial Care in Oncology Summit,” which took place on March 8, 2023, in Washington, DC.

This column summarizes the...

08/08/2023

Journal of Clinical Pathways

Transformative Employer Trends

Gene and Cell Therapies: Changing Employer Plans to Optimize Patient Outcomes

08/08/2023

F. Randy Vogenberg, PhD, FASHP

Alasdair Roe, ACII

This installment of the “Transformative Employer Trends” column explores how employers can expand their benefit plans to include access to gene and cell therapies, while continuing to elevate the role of clinical pathways.

This installment of the...

08/08/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

July/August 2023

Featured Article

Column

Current Issue

Special Reports

Subscribe

August 2023 Volume 9 Issue 4

Specialties

Events

Year Round Education

HMP Global Products